CRP and rheumatoid arthritis: After treatment, the RA patients showed reductions in DAS28-CRP-mediated disease activity (p < 0.0001) (Table 1), body weight (p = 0.014), BMI (p = 0.001), glucose levels (p = 0.022), CRP levels (p = 0.020), total cholesterol (p = 0.0034), as well as the number of swollen joints (p = 0.005) and tender joints (p < 0.0001) (Table 1).